Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_cmfcozkh&referenceId=tag:reuters.com,2025:newsml_RW950812122025RP1_930&pageId=Newscasts
Source: 'Reuters - Business videos'
Description: Shares of cannabis companies soared on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on marijuana. Lisa Bernhard has more.
Short Link: https://lseg.group/44t8NSi
Video Transcript:
Shares of cannabis companies soared on Friday after a report said President Donald Trump is looking to dramatically loosen federal restrictions on marijuana. The Washington Post a day earlier reported that Trump plans to direct federal agencies to reclassify pot as a Schedule III drug. It is currently listed as a Schedule I substance, meaning it has a high potential for abuse and no currently accepted medical use. A shift to Schedule III would reduce oversight of the plant and its derivatives to the same level as some common prescription painkillers and other drugs. Investors reacted quickly to the news with US-listed shares of cannabis company Tilray Brands skyrocketing more than 44% while shares of SNDL, Canopy Growth, and ETF AdvisorShares Pure US Cannabis were up between 24% and 39% in Friday morning trading. The reclassification could also ease criminal penalties regarding marijuana and reshape the industry through potentially lower taxes and easier means of funding. Funding remains one of the biggest challenges for cannabis producers as federal restrictions keep most banks and institutional investors out of the sector, forcing producers to turn to costly loans or alternative lenders. The Drug Enforcement Administration has to review the recommendation and will decide on the reclassification.